Researchers reported, “Compliance with laws restricting stores to selling recreational marijuana to individuals 21 or older presenting a valid ID was high. … Refusal rates exceeded those for alcohol.”
Researchers reported, “Compliance with laws restricting stores to selling recreational marijuana to individuals 21 or older presenting a valid ID was high. … Refusal rates exceeded those for alcohol.”
The transdermal application of plant-derived CBD reduces fascial pain in patients with temporomandibular disorders (TMD aka TMJ), according to clinical data published in the Journal of Clinical Medicine.
Researchers reported: “For the first time, we show a statistically significant negative association between recreational access to cannabis and OTC sleep aid sales.”
Licensed storefronts are now eligible to engage in retail cannabis sales to adults. The first adult-use sales began on Sunday, December 1.
Data published today in the weekly publication of the US Centers for Disease Control and Prevention provides further evidence that the presence of vitamin E acetate (oil) in illicit market, e-liquid vape products is likely associated with EVALI (e-cigarette or vaping product use-associated lung injury).
Authors found “little support for a causal effect of cannabis use on cognition. This conclusion is consistent with those from previous twin studies, which suggest that cannabis use does not cause a decline in cognitive ability among a normative cannabis using sample.”
Representatives of the US Food and Drug Administration issued warning letters on Monday to multiple companies for marketing CBD-specific products in ways that violate federal law.
Authors reported “an independent negative association between frequent cannabis use and frequent illicit opioid use.” Specifically, subjects who consumed cannabis daily “had about 50 percent lower odds of using illicit opioids every day [as] compared to cannabis non-users.”
Select retailers will begin engaging in adult-use marijuana sales next month, according to an advisory issued by the Michigan Marijuana Regulatory Agency.
The Pew survey is the fourth national poll released in recent weeks showing majority support for cannabis legalization.